Vermilion Research

Vermilion’s objective is to deliver timely, actionable, and unique technical research to professional investors through the application of our various technical indicators.

Our research strategists seek to highlight securities which we believe are at major inflection points, based on our various technical and quantitative indicators, and offer asymmetric risk/return profiles. Our unique research methodology, centered on relative strength, enables our strategists to deliver superior investment recommendations.

Our process begins by organizing the universe of actively traded stocks into discrete sectors, then into industry groups. We then apply our technical and quantitative tools to identify developing price trends. Once attractive trends are identified within a selected sector or group, we screen for individual stocks which we believe offer the best risk/reward profile. We provide a historical perspective that often reveals, through our long-term charts, how price patterns often repeat themselves over time.

Technical and Quantitative Research

Technical Analyst, Vermilion Research

Joe Jasper

Technical Analyst

Technical Analysis

MSCI Emerging Markets Index / Technical Analysis

<p>China (MSCI China, Shanghai Comp., Shenzhen A Share) continues to offer many attractive setups and is a major focus in today’s EM Strategy report. Additionally, Taiwan (TAIEX) continues to be worthy of an overweight within the EM universe with the RS uptrend intact. We highlight several attractive set ups.</p>

China (MSCI China, Shanghai Comp., Shenzhen A Share) continues to offer many attractive setups and is a major focus in today’s EM Strategy report. Additionally, Taiwan (TAIEX) continues to be worthy of an overweight within the EM universe with the RS uptrend intact. We highlight several attractive set ups.

Hefei Meiya Optoelectronic Technolgy (002690 CH)

Shanxi Xinghuacun Fen Wine Factory Co (600809 CH)

37 Interactive Entertainment N (002555 CH)

Jiangsu Yangnong Chemical Co,Ltd. (600486 CH)

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd. (600436 CH)

Zhangzhou Pientzehuang Pharmaceutical Co., Ltd.

Zhejiang Wolwo Bio Pharmaceutical (300357 CH)

Shenzhen Inovance Technology Co., (300124 CH)

Shanghai Shenzhen CSI 300 Inde (SHSZ300 INDEX EQUITY)

Shanghai Stock Exchange Composite Index (SHCOMP INDEX)

Taiwan Stock Exchange Weighted Index (TWSE INDEX)

Shenzhen Kangtai Biological Pr (300601 CH)

EM Strategy and Chartbook: Remain Overweight EM Vs. EAFE